canin
parvoviru
ii
parasit
bacteri
enter
iii
canin
distemp
viru
cdv
canin
herpesviru
chv
iv
toxin
foreign
bodi
intussuscept
metabol
diseas
treatment
support
care
may
institut
although
mani
dog
requir
therapi
ii
see
box
treatment
gi
sign
need
routin
ccv
vaccin
question
although
inactiv
modifi
ed
live
viru
mlv
vaccin
avail
atrisk
popul
ii
avoid
exposur
young
puppi
potenti
contamin
environ
iii
ccv
inactiv
variou
disinfect
tabl
iv
viral
shed
may
occur
month
postinfect
pratelli
et
al
cdv
highli
contagi
viru
either
focal
multisystem
manifest
variabl
morbid
mortal
ii
respiratori
gi
neurolog
tissu
target
cdv
ssrna
viru
famili
paramyxovirida
close
relat
measl
viru
primat
rinderpest
domest
livestock
ii
cdv
highli
contagi
larg
viral
concentr
occur
respiratori
secret
b
commonli
spread
aerosol
canin
coronaviru
ccv
caus
contagi
enter
variabl
sever
rare
fatal
young
dog
ii
true
signifi
canc
pathogen
juvenil
diarrhea
fulli
known
may
contribut
morbid
mortal
infecti
enteropathi
canin
parvoviru
cpv
pratelli
et
al
ccv
singlestrand
ss
ribonucl
acid
rna
viru
famili
coronavirida
close
relat
felin
coronaviru
transmiss
gastroenter
viru
pig
ii
ccv
highli
contagi
via
fecalor
transmiss
iii
fecal
shed
result
environment
contamin
import
rout
exposur
iv
ccv
infect
age
group
clinic
diseas
usual
seen
young
puppi
v
ingest
viru
local
villu
tip
small
intestin
replic
result
villou
atrophi
crypt
cell
hyperplasia
c
infect
viru
also
present
urin
bodili
fl
uid
recov
dog
shed
viru
day
postinfect
green
appel
iii
viru
viabl
cold
freez
environ
suscept
heat
dri
ultraviolet
light
iv
younger
anim
suscept
infect
v
suscept
enhanc
older
dog
adequ
vaccin
either
concurr
stress
immunosuppress
condit
vi
system
infect
cdv
contact
upper
respiratori
epithelium
replic
within
respiratori
lymphat
eventu
dissemin
lymphat
tissu
intestin
liver
produc
viremia
host
immun
may
suppress
viru
b
sever
outcom
possibl
depend
immun
antibodi
ab
respons
adequ
immun
viru
clear
ill
box
therapi
gastrointestin
manifest
viral
diseas
b
enrofloxacin
mgkg
sc
bid
dog
rel
contraind
grow
puppi
kitten
owe
potenti
cartilag
damag
c
gentamicin
mgkg
iv
im
sc
sid
amikacin
mgkg
iv
im
sc
sid
contraind
dehydr
hypotens
renal
failur
may
caus
renal
failur
ototox
cover
gramneg
bacteria
cefazolin
mgkg
iv
tid
enrofloxacin
gentocin
e
cefoxitin
mgkg
iv
tid
h
blocker
therapi
may
decreas
gastric
acid
associ
complic
famotidin
mgkg
iv
sc
im
sidbid
b
cimetidin
mgkg
iv
sc
im
tid
c
ranitidin
mgkg
iv
bid
adjunct
therapi
includ
follow
anim
npo
restrict
day
longer
requir
parenter
nutrit
b
whole
blood
pack
rbc
blood
substitut
indic
anemia
c
routin
nurs
care
critic
keep
iv
site
clean
prevent
urin
fecal
scald
recoveri
realiment
import
small
amount
water
offer
hour
cessat
vomit
b
vomit
occur
within
hour
water
administr
small
amount
bland
diet
offer
everi
hour
c
anim
gradual
wean
onto
mainten
requir
bland
diet
day
bland
diet
maintain
week
follow
gradual
reintroduct
diet
appropri
age
isol
sick
dog
ii
matern
ab
usual
gone
week
age
may
interfer
initi
vaccin
green
appel
iii
mlv
vaccin
administ
week
apart
least
one
vaccin
given
matern
ab
wane
annual
triennial
vaccin
current
recommend
booster
protect
tabl
b
measl
vaccin
provid
crossprotect
cdv
may
given
initi
puppi
vaccin
week
matern
ab
interfer
cdv
vaccin
respons
c
inactiv
ie
kill
viru
vaccin
use
pregnant
immunosuppress
anim
confer
lower
degre
durat
immun
mlv
vaccin
mlv
vaccin
contraind
pregnant
immunosuppress
anim
iv
vaccin
complic
occur
enceph
may
develop
sever
immuno
suppress
puppi
puppi
whose
dam
receiv
mlv
vaccin
pregnant
b
cdv
vaccin
inactiv
hyperthermia
attenu
respons
may
occur
concurr
parvoviru
infect
chemotherapi
green
appel
v
recoveri
natur
infect
provid
prolong
immun
vi
cdv
inactiv
variou
disinfect
see
tabl
chv
rel
common
infect
uncommon
caus
diseas
ii
diseas
occur
caus
abort
pregnant
bitch
fatal
hemorrhag
diseas
puppi
week
age
iii
chv
doublestrand
dna
viru
famili
herpesvirida
infect
canida
chv
requir
close
contact
transmiss
ii
spread
transplacent
birth
direct
dogtodog
contact
eg
breed
iii
unstabl
environ
rare
transmit
fomit
consequ
rare
transplacent
infect
includ
abort
stillbirth
weak
puppi
puppi
succumb
neonat
infect
ii
neonat
infect
occur
via
exposur
dam
vagin
secret
birth
infect
litterm
common
fi
rst
week
life
anvik
iii
sign
puppi
week
old
may
less
sever
includ
neurolog
sign
trigemin
neuropathi
ataxia
blind
iv
adult
usual
asymptomat
femal
appear
healthi
may
experi
infertil
abort
stillbirth
b
genit
lesion
includ
papulovesicular
lesion
regress
reappear
male
femal
c
chv
may
play
minor
role
canin
respiratori
infect
latent
infect
recrudesc
immunosuppress
dog
okuda
et
al
limit
use
neonat
sampl
diffi
culti
lack
specifi
citi
b
puppi
thrombocytopenia
evid
dissemin
intravascular
coagulopathi
increas
liver
enzym
activ
particularli
alanin
aminotransferas
ii
chvspecifi
c
test
viru
isol
tissu
affect
puppi
diagnost
b
serolog
test
indic
exposur
diagnos
activ
infect
adult
c
multifoc
hemorrhag
necrosi
inclus
bodi
epitheli
tissu
chv
identifi
ed
tissu
via
fa
em
polymeras
chain
reaction
pcr
assay
also
conclus
neonat
death
bacteri
septicemia
salmonella
spp
streptococcu
spp
b
viral
infect
cdv
c
protozo
diseas
ii
abort
stillbirth
brucellosi
leptospirosi
bacteri
metriti
cdv
protozo
diseas
endocrinopathi
treatment
support
therapi
typic
unsuccess
ii
provid
parenter
fl
uid
oral
iv
dextros
nutrit
support
nurs
care
anim
warm
broadspectrum
antibiot
iii
hyperimmun
serum
recov
dog
may
protect
puppi
week
age
affect
litter
administ
ml
intraperiton
anvik
green
carmichael
iv
rapid
progress
neonat
diseas
make
role
antivir
therapi
question
v
infect
adult
dog
remain
latent
infect
way
clear
viru
bodi
puppi
kept
warm
c
f
lower
morbid
mortal
ii
although
bitch
recov
infect
usual
rais
subsequ
litter
without
problem
recommend
bred
iii
isol
young
puppi
dog
might
shed
viral
particl
iv
prevent
vaccin
avail
europ
v
chv
easili
inactiv
disinfect
see
tabl
cpv
caus
acut
contagi
enter
high
morbid
mortal
immunolog
naiv
dog
ii
rare
myocardi
diseas
result
perinat
infect
canin
ii
ssdna
viru
famili
parvovirida
iii
common
diseasecaus
strain
unit
state
iv
distinct
includ
diseas
manifest
highli
contagi
viru
shed
primarili
fece
infect
recov
anim
b
fomit
common
sourc
exposur
direct
contact
fece
persist
environ
c
incid
higher
summer
late
fall
houston
et
al
immunolog
naiv
anim
young
puppi
suscept
infect
howev
older
immunocompromis
anim
also
risk
e
report
breed
predisposit
includ
rottweil
american
pit
bull
terrier
doberman
pinscher
german
shepherd
dog
houston
et
al
oronas
exposur
primari
rout
initi
replic
occur
local
lymphoid
tissu
subsequ
viremia
day
b
rapidli
divid
tissu
eg
intestin
crypt
cell
bone
marrow
leukocyt
precursor
preferenti
infect
dissemin
lung
kidney
myocardium
possibl
adjunct
therapi
involv
hyperimmun
plasma
transfus
mlkg
iv
recov
dog
cohn
la
unpublish
data
b
empir
deworm
use
elimin
concurr
intestin
parasit
c
treatment
recombin
human
granulocyt
colonystimul
factor
gcsf
benefi
cial
rewert
et
al
infect
may
fatal
mani
anim
fulli
recov
iii
myocardi
diseas
extrem
diffi
cult
treat
diseas
rapidli
progress
fatal
therapeut
intervent
rare
attempt
b
treat
congest
heart
failur
survivor
quarantin
unvaccin
anim
ii
passiv
immun
import
neonat
matern
ab
titer
hemagglutinationinhibit
protect
mccaw
et
al
b
matern
ab
typic
protect
week
may
interfer
vaccin
respons
week
age
coyn
iii
good
acquir
immun
achiev
vaccin
hightit
potenti
mlv
vaccin
prefer
induc
protect
immun
puppi
matern
ab
present
larson
schultz
annual
mccaw
et
al
triennial
booster
vaccin
see
tabl
recommend
b
lowtit
mlv
vaccin
alway
protect
puppi
high
matern
ab
level
even
week
age
vaccin
provid
adequ
protect
older
puppi
adult
hoskin
iv
follow
natur
infect
recov
anim
longlast
immun
v
viru
resist
disinfect
see
tabl
onset
cn
sign
usual
week
depend
viral
load
inocul
degre
innerv
site
proxim
site
cn
strain
rv
ii
classic
clinic
present
either
furiou
paralyt
case
fi
categori
combin
sign
possibl
iii
furiou
form
rabi
diseas
cours
last
day
behavior
chang
hyperexcit
hyperesthesia
aggress
occur
b
ataxia
seizur
develop
follow
death
iv
paralyt
form
diseas
cours
typic
last
week
progress
ascend
lower
motor
neuron
paralysi
begin
inocul
site
lead
dysphagia
masticatori
muscl
paralysi
laryng
pharyng
dysfunct
classic
sign
saliv
b
death
caus
respiratori
paralysi
histori
recent
bite
wound
classic
clinic
present
may
help
ii
clinic
patholog
fi
nding
nonspecifi
c
iii
antemortem
test
may
confi
rm
rv
infect
adequ
rule
iv
owe
seriou
public
health
implic
euthanasia
anim
suspect
rv
infect
urgent
recommend
often
requir
law
v
postmortem
test
confi
rm
deni
diagnosi
submit
brainchil
frozena
soon
possibl
state
diagnost
laboratori
b
direct
fa
test
brain
diagnost
method
choic
c
addit
test
brain
specimen
includ
pcr
viral
particl
histopatholog
evalu
intracellular
inclus
negri
bodi
mous
inocul
kasempimolporn
et
al
rv
strain
may
identifi
ed
help
determin
sourc
exposur
vaccin
provid
excel
protect
diseas
vaccin
state
initi
kill
vaccin
week
age
booster
vaccin
year
age
follow
triennial
booster
b
state
requir
yearli
vaccin
vaccin
approv
yearli
use
eg
canari
poxvector
vaccin
c
use
rabi
vaccin
associ
injectionsit
sarcoma
cat
ii
municip
rabi
vaccin
dog
cat
requir
law
iii
recommend
preexposur
vaccin
manag
postexposur
manag
avail
yearli
american
veterinari
medic
associ
avma
wwwavmaorgissuespolicyrabiescontrolasp
center
diseas
control
prevent
cdc
wwwcdcgovncidoddvrdrabi
see
tabl
iv
use
extrem
care
handl
anim
bodili
fl
uid
rv
infect
suspect
v
rv
suscept
disinfect
surviv
well
environ
see
tabl
felin
coronaviru
fcov
caus
either
subclin
infect
mild
transient
diarrhea
expos
cat
ii
spontan
mutat
enter
fcov
may
lead
clinic
fip
associ
high
morbid
mortal
iii
fcov
ssrna
viru
famili
coronavirida
fcov
highli
contagi
via
fecalor
transmiss
salivari
urinari
transplacent
sourc
exposur
uncommon
ii
infect
cat
shed
viru
intermitt
stop
shed
although
shed
persist
iii
fcov
mutat
fipcaus
form
seldom
shed
fece
epizoot
rare
iv
although
inactiv
disinfect
fcov
may
persist
environ
see
tabl
v
enter
infect
result
villou
atrophi
mild
selflimit
diarrhea
vi
fip
histori
recent
stress
ill
may
preced
diseas
mutat
fcov
invad
intestin
epithelium
enter
macrophag
result
dissemin
spread
mutat
viral
particl
b
immunolog
respons
ineffect
patholog
chang
occur
c
two
form
fip
recogn
effus
wet
form
immun
complex
circul
deposit
endothelia
b
vascul
ensu
exud
proteinrich
fl
uid
bodi
caviti
c
wet
form
usual
rapidli
progress
dri
form
ineffect
cellmedi
immun
respons
mount
viru
b
pyogranulomat
infl
ammat
varieti
tissu
result
diseas
c
dri
form
may
becom
effus
termin
stage
enter
fcov
often
subclin
mild
diarrhea
ii
fip
young
year
elderli
cat
commonli
affect
b
sexual
intact
purebr
cat
commonli
affect
c
effus
fip
remov
kitten
seroposit
queen
week
age
avail
intranas
vaccin
appear
safe
use
direct
temperaturesensit
vaccin
viru
replic
respiratori
epithelium
induc
mucos
immun
vaccin
effi
caci
previous
unexpos
cat
pederson
indic
lowrisk
cat
adult
cat
singlecat
household
atrisk
kitten
possibl
benefi
vaccin
two
dose
given
week
apart
follow
yearli
booster
vaccin
current
vaccin
recommend
routin
use
tabl
b
vaccin
prevent
mutat
fcov
infect
cat
fiv
caus
chronic
infect
long
subclin
period
eventu
develop
acquir
immunodefi
cienci
associ
clinic
syndrom
ii
fiv
lentiviru
ssrna
viru
famili
retrovirida
infect
felida
close
relat
human
immunodefi
cienci
viru
epidemiolog
fi
nding
horizont
vertic
transmiss
occur
vertic
spread
epidemiolog
import
b
close
contact
requir
transmiss
fomit
involv
minim
c
horizont
transmiss
occur
primarili
via
bite
wound
also
occur
via
blood
transfus
contamin
needl
instrument
contact
bodili
fl
uid
male
particularli
intact
outdoor
cat
fi
ght
commonli
infect
femal
e
adult
middl
age
older
infect
often
kitten
f
higher
seropreval
fiv
occur
area
larg
outdoor
cat
popul
fiv
initi
replic
lymphoid
includ
thymic
salivari
tissu
subsequ
dissemin
mani
tissu
b
cat
mount
partial
effect
immun
respons
number
circul
viral
particl
lessen
cat
appear
healthi
c
subclin
period
possibl
mani
year
gradual
deterior
immun
function
occur
true
latenc
secondari
infect
associ
ill
eventu
occur
result
termin
phase
diseas
acut
infect
may
inappar
caus
selflimit
fever
neutropenia
lymphadenopathi
ii
lymphadenopathi
variabl
present
subclin
period
month
year
iii
clinic
ill
varieti
manifest
recurr
fever
anorexia
malais
gingiv
stomat
common
b
secondari
infect
gi
respiratori
urinari
tract
c
infl
ammatori
diseas
eye
hartmann
varieti
malign
hutson
et
al
e
rare
peripher
central
neurolog
dysfunct
podel
et
al
f
sever
weight
loss
cytopenia
termin
lymphopenia
neutropenia
acut
later
stage
diseas
b
anemia
thrombocytopenia
ii
serum
biochemistri
profi
le
hyperglobulinemia
fi
nding
relat
secondari
diseas
iii
cytolog
evalu
fi
neneedl
aspir
enlarg
lymph
node
hyperplasia
mimic
lymphoma
iv
fivspecifi
c
diagnost
test
inhospit
elisa
test
identifi
ab
fiv
alway
detect
acut
infect
termin
stage
fals
posit
occur
matern
ab
retest
posit
kitten
month
age
sellon
fals
posit
occur
vaccin
cat
b
although
western
blot
use
confi
rmatori
test
posit
elisa
result
distinguish
ab
form
respons
infect
matern
ab
ab
form
respons
vaccin
levi
et
al
c
pcr
assay
avail
vari
greatli
reliabl
crawford
et
al
provid
support
care
prompt
therapi
secondari
infect
b
human
recombin
gcsf
may
help
sever
neutropenia
see
treatment
felin
leukemia
viru
c
use
recombin
human
granulocytemacrophag
coloni
stimul
factor
may
lead
increas
fiv
load
arai
et
al
immun
modul
antivir
therapi
may
tri
see
treatment
felin
leukemia
viru
vaccin
avail
confer
perfect
protect
huang
et
al
tabl
ii
discourag
fi
ghting
breed
infect
cat
iii
ideal
separ
fivposit
cat
fivneg
housem
howev
unless
fi
ght
risk
transmiss
normal
contact
eg
share
litter
box
food
bowl
low
arai
et
al
address
caus
anemia
hemotroph
mycoplasma
spp
infect
imha
b
neutropenia
use
human
recombin
gcsf
mgkgday
sc
week
sever
neutropenia
controversi
obradovich
et
al
hartmann
arai
et
al
higher
dose
longer
period
may
caus
product
antibodi
felin
coloni
stimul
factor
consid
prophylact
antibiot
iv
secondari
bacteri
infect
requir
prompt
therapi
appropri
antibiot
v
immun
modul
antivir
therapi
may
tri
evid
effi
caci
slim
mccaw
et
al
staphylococcu
aureu
protein
mgkg
ip
twice
weekli
b
human
recombin
interferona
u
po
sid
altern
week
c
felin
recombin
interferon
omega
ukgday
sc
consecut
day
seri
begin
day
de
mari
et
al
isol
cat
felv
noninfect
cat
keep
infect
cat
indoor
vaccin
infecti
diseas
breed
ii
vaccin
involv
follow
see
tabl
test
felv
vaccin
vaccin
posit
cat
provid
benefi
ts
b
vaccin
indic
lowrisk
cat
eg
indoor
cat
singlecat
household
household
cat
test
neg
c
kill
subunit
vaccin
equal
effi
caciou
vaccin
effi
caci
estim
true
efficaci
vari
legendr
et
al
jarret
ganier
e
initi
give
two
vaccin
week
apart
annual
booster
vaccin
f
use
felv
vaccin
associ
injectionsit
sarcoma
cat
felin
panleukopenia
highli
contagi
acut
enter
diseas
young
cat
typic
accompani
sever
leukopenia
high
morbid
mortal
ii
utero
earli
neonat
infect
may
caus
cerebellar
diseas
iii
felin
parvoviru
fpv
ssdna
viru
famili
parvovirida
relat
rare
isol
cat
panleukopenia
fpv
highli
contagi
domest
wild
member
famili
felida
b
viru
shed
bodi
secret
fecal
shed
primari
sourc
infect
c
transmiss
contact
infect
anim
contamin
environ
fomit
fpv
seldom
encount
vaccin
domest
cat
problemat
feral
shelter
stray
cat
e
diseas
common
kitten
cat
year
old
immun
subclin
infect
younger
kitten
protect
matern
ab
ii
pathogenesi
oronas
exposur
viru
replic
region
lymph
node
caus
viremia
b
fpv
preferenti
infect
rapidli
divid
cell
eg
intestin
epitheli
cell
lymph
tissu
hematopoiet
cell
bone
marrow
c
secondari
gi
bacteri
infect
transloc
gut
bacteria
increas
suscept
bacteri
infect
sepsi
contribut
clinic
sign
produc
